Tag: FDA approval process

news-14082024-234924

Humacyte Stock Drops 18% Due to FDA Delay for ATEV (NASDAQ:HUMA)

Humacyte, a biotechnology company listed on the NASDAQ under the ticker symbol HUMA, experienced a significant drop in its stock price of 18% in...